Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | VRSK | MRK |
|---|---|---|
| Price | $168.79 | $144.17 |
| Change today | ▲ 0.56% | ▼ 0.78% |
| Market cap | $21.97B | $355.69B |
| Return, 3 months | -7.9% | +15.0% |
| Return, year to date | -23.9% | +39.0% |
| Return, 1 year | -31.7% | +63.7% |
| P/E (TTM) | 25.9 | 115.3 |
| P/B | -18.5 | 8.5 |
| P/E percentile vs own 5y | 1st | 89th |
| Dividend yield | 1.13% | 2.33% |
| Revenue growth (YoY, latest qtr) | +4.4% | +5.1% |
| Net profit growth (YoY) | -9.8% | -130.2% |
| Gross margin | 70.2% | 73.0% |
| Operating margin | 43.9% | 10.5% |
| Net margin | 28.2% | 4.8% |
| Return on equity | – | 7.0% |
| Analyst target vs. price | +39.6% | +13.2% |
| Analyst buy share | 54% | 83% |
| RSI (14) | 37 | 48 |
| 30-day volatility | 35.5% | 42.4% |
| Max drawdown, 1 year | -37.4% | -11.4% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
